Stressing mitosis to death

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Burgess, Andrew ^a,b   Rasouli, Mina ^a   Rogers, Samuel ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cdk1; Checkpoint; DNA damage; Kinetochore; Metaphase; Mitosis; SAC; Spindle

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATM PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); PHOSPHOPROTEIN PHOSPHATASE 2; REACTIVE OXYGEN METABOLITE;

CELL DEATH; CELLULAR STRESS RESPONSE; CHROMATIN STRUCTURE; CHROMOSOME CONDENSATION; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; HYPERTHERMIA; HYPOTHERMIA; HYPOXIA; M PHASE CELL CYCLE CHECKPOINT; MECHANICAL STRESS; MITOSIS; MITOSIS INHIBITION; OSMOTIC PRESSURE; OVARY CANCER; OXIDATIVE STRESS; PROTEIN ANALYSIS; RNA TRANSLATION; SHORT SURVEY;

EID: 84904640532     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00140     Document Type: Short Survey

References (118)

1. Sherr CJ. Cancer cell cycles. Science (1996) 274:1672-7. doi: 10.1126/science.274.5293.1672
2. Pearce AK, Humphrey TC. Integrating stress-response and cell-cycle checkpoint pathways. Trends Cell Biol (2001) 11:426-33. doi:10.1016/S0962-8924(01)02119-5
3. Lara-Gonzalez P, Westhorpe FG, Taylor SS. The spindle assembly checkpoint. Curr Biol (2012) 22:R966-80. doi:10.1016/j.cub.2012.10.006
4. Overlack K, Krenn V, Musacchio A. When Mad met Bub. EMBO Rep (2014) 15:326-8. doi:10.1002/embr.201438574
5. Brito DA, Rieder CL. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol (2006) 16:1194-200. doi:10.1016/j.cub.2006.04.043
6. Potapova TA, Daum JR, Pittman BD, Hudson JR, Jones TN, Satinover DL, et al. The reversibility of mitotic exit in vertebrate cells. Nature (2006) 440:954-8. doi:10.1038/nature04652
7. McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle (2014) 13:1400-12. doi:10.4161/cc.28401
8. Bakhoum SF, Silkworth WT, Nardi IK, Nicholson JM, Compton DA, Cimini D. The mitotic origin of chromosomal instability. Curr Biol (2014) 24:R148-9. doi:10.1016/j.cub.2014.01.019
9. Konrad CG. Protein synthesis and RNA synthesis during mitosis in animal cells. J Cell Biol (1963) 19:267-77. doi:10.1083/jcb.19.2.267
10. Fan H, Penman S. Regulation of protein synthesis in mammalian cells. II. Inhibition of protein synthesis at the level of initiation during mitosis. J Mol Biol (1970) 50:655-70. doi:10.1016/0022-2836(70)90091-4
11. van Vugt MA, Gardino AK, Linding R, Ostheimer GJ, Reinhardt HC, Ong S-E, et al. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to Inactivate the G2/M DNA damage checkpoint. PLoS Biol (2010) 8:e1000287. doi:10.1371/journal.pbio.1000287
12. Kim H-S, Heo J-I, Park S-H, Shin J-Y, Kang H-J, Kim M-J, et al. Transcriptional activation of p21(WAF1/CIP1) is mediated by increased DNA binding activity and increased interaction between p53 and Sp1 via phosphorylation during replicative senescence of human embryonic fibroblasts. Mol Biol Rep (2014) 41:2397-408. doi:10.1007/s11033-014-3094-9
13. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem (2001) 276:29116-25. doi:10.1074/jbc.M104130200
14. Martínez-Balbás MA, Dey A, Rabindran SK, Ozato K, Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell (1995) 83:29-38. doi:10.1016/0092-8674(95)90231-7
15. Kadauke S, Blobel GA. Mitotic bookmarking by transcription factors. Epigenetics Chromatin (2013) 6:6. doi:10.1186/1756-8935-6-6
16. Chen D, Dundr M, Wang C, Leung A, Lamond A, Misteli T, et al. Condensed mitotic chromatin is accessible to transcription factors and chromatin structural proteins. J Cell Biol (2005) 168:41-54. doi:10.1083/jcb.200407182
17. Long JJ, Leresche A, Kriwacki RW, Gottesfeld JM. Repression of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity at mitosis. Mol Cell Biol (1998) 18:1467-76.
18. Chuang J-Y, Wang S-A, Yang W-B, Yang H-C, Hung C-Y, Su T-P, et al. Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene (2012) 31:4946-59. doi:10.1038/onc.2011.649
19. Sansregret L, Gallo D, Santaguida M, Leduy L, Harada R, Nepveu A. Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle. J Biol Chem (32843) 285(2010):32834-43. doi:10.1074/jbc.M110.156406
20. Vadnais C, Davoudi S, Afshin M, Harada R, Dudley R, Clermont P-L, et al. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage. Nucleic Acids Res (2012) 40:4483-95. doi:10.1093/nar/gks041
21. Shiromizu T, Goto H, Tomono Y, Bartek J, Totsukawa G, Inoko A, et al. Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1). Genes Cells (2006) 11:477-85. doi:10.1111/j.1365-2443.2006.00955.x
22. Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science (2014) 344:189-93. doi:10.1126/science.1248024
23. Petsalaki E, Zachos G. Chk2 prevents mitotic exit when the majority of kinetochores are unattached. J Cell Biol (2014) 205:339-56. doi:10.1083/jcb.201310071
24. Yang C, Tang X, Guo X, Niikura Y, Kitagawa K, Cui K, et al. Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. Mol Cell (2011) 44:597-608. doi:10.1016/j.molcel.2011.09.016
25. Eliezer Y, Argaman L, Kornowski M, Roniger M, Goldberg M. Interplay between the DNA damage proteins MDC1 and ATM in the regulation of the spindle assembly checkpoint. J Biol Chem (2014) 289:8182-93. doi:10.1074/jbc.M113.532739
26. Oricchio E, Saladino C, Iacovelli S, Soddu S, Cundari E. ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity. Cell Cycle (2006) 5:88-92. doi:10.4161/cc.5.1.2269
27. Palazzo L, Della Monica R, Visconti R, Costanzo V, Grieco D. ATM controls proper mitotic spindle structure. Cell Cycle (2014) 13:1091-100. doi:10.4161/cc.27945
28. Pyronnet S, Pradayrol L, Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell (2000) 5:607-16. doi:10.1016/S1097-2765(00)80240-3
29. Pyronnet S, Dostie J, Sonenberg N. Suppression of cap-dependent translation in mitosis. Genes Dev (2001) 15:2083-93. doi:10.1101/gad.889201
30. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell (2000) 5:597-605. doi:10.1016/S1097-2765(00)80239-7
31. Qin X, Sarnow P. Preferential translation of internal ribosome entry site-containing mRNAs during the mitotic cycle in mammalian cells. J Biol Chem (2004) 279:13721-8. doi:10.1074/jbc.M312854200
32. Groisman I, Huang YS, Mendez R, Cao Q, Theurkauf W, Richter JD. CPEB, maskin, and cyclin B1 mRNA at the mitotic apparatus: implications for local translational control of cell division. Cell (2000) 103:435-47. doi:10.1016/S0092-8674(00)00135-5
33. Blower MD, Feric E, Weis K, Heald R. Genome-wide analysis demonstrates conserved localization of messenger RNAs to mitotic microtubules. J Cell Biol (2007) 179:1365-73. doi:10.1083/jcb.200705163
34. Manchado E, Guillamot M, Malumbres M. Killing cells by targeting mitosis. Cell Death Differ (2012) 19:369-77. doi:10.1038/cdd.2011.197
35. Skoufias DA, Lacroix FB, Andreassen PR, Wilson L, Margolis RL. Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol Cell (2004) 15:977-90. doi:10.1016/j.molcel.2004.08.018
36. Uetake Y, Sluder G. Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis. Curr Biol (2010) 20:1666-71. doi:10.1016/j.cub.2010.08.018
37. Mikhailov A, Cole RW, Rieder CL. DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr Biol (2002) 12:1797-806. doi:10.1016/S0960-9822(02)01226-5
38. Hayashi MT, Cesare AJ, Fitzpatrick JAJ, Lazzerini-Denchi E, Karlseder J. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat Struct Mol Biol (2012) 19:387-94. doi:10.1038/nsmb.2245
39. Charbin A, Bouchoux C, Uhlmann F. Condensin aids sister chromatid decatenation by topoisomerase II. Nucleic Acids Res (2014) 42:340-8. doi:10.1093/nar/gkt882
40. Choi E, Lee H. Chromosome damage in mitosis induces BubR1 activation and prometaphase arrest. FEBS Lett (2008) 582:1700-6. doi:10.1016/j.febslet.2008.04.028
41. Wang LH-C, Mayer B, Stemmann O, Nigg EA. Centromere DNA decatenation depends on cohesin removal and is required for mammalian cell division. J Cell Sci (2010) 123:806-13. doi:10.1242/jcs.058255
42. d'Alcontres MS, Palacios JA, Mejias D, Blasco MA. TopoIIa prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres. Cell Cycle (2014) 13:1463-81. doi:10.4161/cc.28419
43. Toyoda Y, Yanagida M. Coordinated requirements of human topo II and cohesin for metaphase centromere alignment under Mad2-dependent spindle checkpoint surveillance. Mol Biol Cell (2006) 17:2287-302. doi:10.1091/mbc.E05-11-1089
44. Mikhailov A, Shinohara M, Rieder CL. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol (2004) 166:517-26. doi:10.1083/jcb.200405167
45. Tokalov SV, Abramyuk AM, Abolmaali ND. Protection of p53 wild type cells from taxol by genistein in the combined treatment of lung cancer. Nutr Cancer (2010) 62:795-801. doi:10.1080/01635581003605912
46. Smith PJ, Marquez N, Wiltshire M, Chappell S, Njoh K, Campbell L, et al. Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle (2007) 6:2071-81. doi:10.4161/cc.6.16.4585
47. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 2:672-6. doi:10.1038/35023629
48. Liu D, Davydenko O, Lampson MA. Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing. J Cell Biol (2012) 198:491-9. doi:10.1083/jcb.201205090
49. Yuan J-H, Feng Y, Fisher RH, Maloid S, Longo DL, Ferris DK. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase. Mol Cancer Res (2004) 2: 417-26.
50. Jang Y-J, Ji J-H, Choi Y-C, Ryu CJ, Ko S-Y. Regulation of polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A. J Biol Chem (2007) 282:2473-82. doi:10.1074/jbc.M605480200
51. Vasey PA, Jones NA, Jenkins S, Dive C, Brown R. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Mol Pharmacol (1996) 50:1536-40.
52. McGuire WP. Current status of taxane and platinum-based chemotherapy in ovarian cancer. J Clin Oncol (2003) 21:133s-5s. doi:10.1200/JCO.2003.01.066
53. Sculier JP, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, et al. A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer. Ann Oncol (2007) 18:1037-42. doi:10.1093/annonc/mdm084
54. Papadopoulos NE, Bedikian A, Ring S, Kim KB, Hwu W-J, Gerber DL, et al. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma. Am J Clin Oncol (2009) 32:509-14. doi:10.1097/COC.0b013e3181942a1f
55. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 369:1691-703. doi:10.1056/NEJMoa1304369
56. Robbins AR, Jablonski SA, Yen TJ, Yoda K, Robey R, Bates SE, et al. Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. Cell Cycle (2005) 4:717-26. doi:10.4161/cc.4.5.1690
57. Warrener R, Beamish H, Burgess A, Waterhouse NJ, Giles N, Fairlie D, et al. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. FASEB J (2003) 17:1550-2. doi:10.1096/fj.02-1003fje
58. Magnaghi-Jaulin L, Eot-Houllier G, Fulcrand G, Jaulin C. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint. Cancer Res (2007) 67:6360-7. doi:10.1158/0008-5472.CAN-06-3012
59. Stevens FE, Beamish H, Warrener R, Gabrielli B. Histone deacetylase inhibitors induce mitotic slippage. Oncogene (2008) 27:1345-54. doi:10.1038/sj.onc.1210779
60. Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell (2004) 5:405-6. doi:10.1016/S1535-6108(04)00118-7
61. Pandey R, Heeger S, Lehner CF. Rapid effects of acute anoxia on spindle kinetochore interactions activate the mitotic spindle checkpoint. J Cell Sci (2007) 120:2807-18. doi:10.1242/jcs.007690
62. Dong XL, Xu PF, Miao C, Fu ZY, Li QP, Tang PY, et al. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1. Biomed Pharmacother (2012) 66:70-5. doi:10.1016/j.biopha.2011.11.016
63. Rofstad EK, Johnsen NM, Lyng H. Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro. Br J Cancer Suppl (1996) 27:S136-9.
64. Ohshima S. Abnormal mitosis in hypertetraploid cells causes aberrant nuclear morphology in association with H2O2-induced premature senescence. Cytometry (2008) 73A:808-15. doi:10.1002/cyto.a.20604
65. Ren Q, Liou L-C, Gao Q, Bao X, Zhang Z. Bir1 deletion causes malfunction of the spindle assembly checkpoint and apoptosis in yeast. Front Oncol (2012) 2:93. doi:10.3389/fonc.2012.00093
66. Lee C-F, Liu C-Y, Hsieh R-H, Wei Y-H. Oxidative stress-induced depolymerization of microtubules and alteration of mitochondrial mass in human cells. Ann N Y Acad Sci (2005) 1042:246-54. doi:10.1196/annals.1338.027
67. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer (2010) 10:194-204. doi:10.1038/nrc2803
68. Lissoni P, Barni S, Mandalà M, Ardizzoia A, Paolorossi F, Vaghi M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer (1999) 35:1688-92. doi:10.1016/S0959-8049(99)00159-8
69. Liang Y-C, Tsai S-H, Chen L, Lin-Shiau S-Y, Lin J-K. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol (2003) 65:1053-60. doi:10.1016/S0006-2952(03)00011-X
70. Lu X, Jung JI, Cho HJ, Lim DY, Lee HS, Chun HS, et al. Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr (2005) 135:2884-90.
71. Mao Q-Q, Bai Y, Lin Y-W, Zheng X-Y, Qin J, Yang K, et al. Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines. Mol Nutr Food Res (2010) 54:1574-84. doi:10.1002/mnfr.200900392
72. Salmela A-L, Pouwels J, Varis A, Kukkonen AM, Toivonen P, Halonen PK, et al. Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis (2009) 30:1032-40. doi:10.1093/carcin/bgp101
73. Lee GM. Characterization of mitotic motors by their relative sensitivity to AMP-PNP. J Cell Sci (1989) 94(Pt 3):425-41.
74. Spurck TP, Pickett-Heaps JD. On the mechanism of anaphase A: evidence that ATP is needed for microtubule disassembly and not generation of polewards force. J Cell Biol (1987) 105:1691-705. doi:10.1083/jcb.105.4.1691
75. Wadsworth P, Salmon ED. Spindle microtubule dynamics: modulation by metabolic inhibitors. Cell Motil Cytoskeleton (1988) 11:97-105. doi:10.1002/cm.970110203
76. Thaiparambil JT, Eggers CM, Marcus AI. AMPK regulates mitotic spindle orientation through phosphorylation of myosin regulatory light chain. Mol Cell Biol (2012) 32:3203-17. doi:10.1128/MCB.00418-12
77. Howell BJ, McEwen BF, Canman JC, Hoffman DB, Farrar EM, Rieder CL, et al. Cytoplasmic dynein/dynactin drives kinetochore protein transport to the spindle poles and has a role in mitotic spindle checkpoint inactivation. J Cell Biol (2001) 155:1159-72. doi:10.1083/jcb.200105093
78. Howell BJ, Hoffman DB, Fang G, Murray AW, Salmon ED. Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at spindle poles in living cells. J Cell Biol (2000) 150:1233-50. doi:10.1083/jcb.150.6.1233
79. Hoffman DB, Pearson CG, Yen TJ, Howell BJ, Salmon ED. Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores. Mol Biol Cell (2001) 12:1995-2009. doi:10.1091/mbc.12.7.1995
80. Hanna RK, Zhou C, Malloy KM, Sun L, Zhong Y, Gehrig PA, et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol Oncol (2012) 125:458-69. doi:10.1016/j.ygyno.2012.01.009
81. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 3:487-97. doi:10.1016/S1470-2045(02)00818-5
82. Coss RA, Dewey WC, Bamburg JR. Effects of hyperthermia (41.5 degrees) on Chinese hamster ovary cells analyzed in motisis. Cancer Res (1979) 39:1911-8.
83. Pawlik A, Nowak JM, Grzanka D, Gackowska L, Michalkiewicz J, Grzanka A. Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells. Acta Histochem (2013) 115:8-15. doi:10.1016/j.acthis.2012.02.006
84. Vihervaara A, Sergelius C, Vasara J, Blom MAH, Elsing AN, Roos-Mattjus P, et al. Transcriptional response to stress in the dynamic chromatin environment of cycling and mitotic cells. Proc Natl Acad Sci U S A (2013) 110:E3388-97. doi:10.1073/pnas.1305275110
85. Xing H, Wilkerson DC, Mayhew CN, Lubert EJ, Skaggs HS, Goodson ML, et al. Mechanism of hsp70i gene bookmarking. Science (2005) 307:421-3. doi:10.1126/science.1106478
86. Coss RA, Dewey WC, Bamburg JR. Effects of hyperthermia on dividing Chinese hamster ovary cells and on microtubules in vitro. Cancer Res (1982) 42:1059-71.
87. Gupta RK, Srinivas UK. Heat shock induces chromosomal instability in near-tetraploid embryonal carcinoma cells. Cancer Biol Ther (2008) 7:1471-80. doi:10.4161/cbt.7.9.6428
88. Giovinazzi S, Bellapu D, Morozov VM, Ishov AM. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy. Cell Cycle (2013) 12:2598-607. doi:10.4161/cc.25591
89. Leal BZ, Meltz ML, Mohan N, Kuhn J, Prihoda TJ, Herman TS. Interaction of hyperthermia with taxol in human MCF-7 breast adenocarcinoma cells. Int J Hyperthermia (1999) 15:225-36. doi:10.1080/026567399285747
90. Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature (2011) 471:110-4. doi:10.1038/nature09779
91. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell (2008) 14:111-22. doi:10.1016/j.ccr.2008.07.002
92. Matijasevic Z. Selective protection of non-cancer cells by hypothermia. Anticancer Res (2002) 22:3267-72.
93. Zhang XM, Lv YG, Chen GB, Zou Y, Lin CW, Yang L, et al. Effect of mild hypothermia on breast cancer cells adhesion and migration. Biosci Trends (2012) 6:313-24. doi:10.5582/bst.2012.v6.6.313
94. Rieder CL. Effect of hypothermia (20-25°C) on mitosis in PtK1 cells. Cell Biol Int Rep (1981) 5:563-73. doi:10.1016/S0309-1651(81)80007-0
95. Wise D, Cassimeris L, Rieder CL, Wadsworth P, Salmon ED. Chromosome fiber dynamics and congression oscillations in metaphase PtK2 cells at 23°C. Cell Motil Cytoskeleton (1991) 18:131-42. doi:10.1002/cm.970180208
96. Cassimeris L, Rieder CL, Rupp G, Salmon ED. Stability of microtubule attachment to metaphase kinetochores in PtK1 cells. J Cell Sci (1990) 96(Pt 1):9-15.
97. Shannon KB, Canman JC, Salmon ED. Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension. Mol Biol Cell (2002) 13:3706-19. doi:10.1091/mbc.E02-03-0137
98. Vig BK. Effect of hypothermia and hyperthermia on the induction of chromosome aberrations by adriamycin in human leukocytes. Cancer Res (1978) 38:550-5.
99. Lemenager M, Lecomte S, Bonneterre ME, Bessa E, Dauba J, Bonneterre J. Effectiveness of cold cap in the prevention of docetaxel-induced alopecia. Eur J Cancer (1997) 33:297-300. doi:10.1016/S0959-8049(96)00374-7
100. Mitchison TJ. Actin based motility on retraction fibers in mitotic PtK2 cells. Cell Motil Cytoskeleton (1992) 22:135-51. doi:10.1002/cm.970220207
101. Stewart MP, Helenius J, Toyoda Y, Ramanathan SP, Muller DJ, Hyman AA. Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding. Nature (2011) 469:226-30. doi:10.1038/nature09642
102. Maddox AS, Burridge K. RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol (2003) 160:255-65. doi:10.1083/jcb.200207130
103. Matthews HK, Delabre U, Rohn JL, Guck J, Kunda P, Baum B. Changes in Ect2 localization couple actomyosin-dependent cell shape changes to mitotic progression. Dev Cell (2012) 23:371-83. doi:10.1016/j.devcel.2012.06.003
104. Lancaster OM, Le Berre M, Dimitracopoulos A, Bonazzi D, Zlotek-Zlotkiewicz E, Picone R, et al. Mitotic rounding alters cell geometry to ensure efficient bipolar spindle formation. Dev Cell (2013) 25:270-83. doi:10.1016/j.devcel.2013.03.014
105. Bakal CJ, Finan D, LaRose J, Wells CD, Gish G, Kulkarni S, et al. The Rho GTP exchange factor Lfc promotes spindle assembly in early mitosis. Proc Natl Acad Sci U S A (2005) 102:9529-34. doi:10.1073/pnas.0504190102
106. Heng Y-W, Lim HH, Mina T, Utomo P, Zhong S, Lim C-T, et al. TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation. J Cell Sci (2012) 125:1579-90. doi:10.1242/jcs.096818
107. Wheatley DN. Hypertonicity and the arrest of mammalian cells in metaphase: a synchrony technique for HeLa cells. J Cell Sci (1974) 15:221-37.
108. Wheatley DN. Cell-growth and division in hypertonic medium. Exp Cell Res (1974) 87:219-32. doi:10.1016/0014-4827(74)90474-1
109. Reiser V, D'Aquino KE, Ee L-S, Amon A. The stress-activated mitogen-activated protein kinase signaling cascade promotes exit from mitosis. Mol Biol Cell (2006) 17:3136-46. doi:10.1091/mbc.E05-12-1102
110. Mocciaro A, Schiebel E. Cdc14: a highly conserved family of phosphatases with non-conserved functions? J Cell Sci (2010) 123:2867-76. doi:10.1242/jcs.074815
111. Burgess A, Vigneron S, Brioudes E, Labbé J-C, Lorca T, Castro A. Loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A (12569) 107(2010):12564-9. doi:10.1073/pnas.0914191107
112. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol (2010) 12:886-93. doi:10.1038/ncb2092
113. Huges A. Some effects of abnormal tonicity on dividing cells in chick tissue cultures. Q J Microsc Sci (1952) 93:207-19.
114. Ford JH, Congedi MM. Rapid induction of anaphase in competent cells by hypotonic treatment. Cytobios (1987) 51:183-92.
115. Brinkley BR, Cox SM, Pepper DA. Structure of the mitotic apparatus and chromosomes after hypotonic treatment of mammalian cells in vitro. Cytogenet Cell Genet (1980) 26:165-74. doi:10.1159/000131438
116. Nowak C. Studies on the ability of hypotonic solutions to induce chromosomal aberrations in V 79 cell. Teratog Carcinog Mutagen (1987) 7:515-25. doi:10.1002/tcm.1770070603
117. Stephen RL, Novak JM, Jensen EM, Kablitz C, Buys SS. Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cells. Cancer Res (1990) 50:4704-8.
118. Katano K, Tsujitani S, Saito H, Ikeguchi M, Maeta M, Kaibara N. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model. Anticancer Res (1997) 17:4547-52.